https://ambrygen.com/science/scientific-presentations 2026-04-27T11:19:53+00:00 https://ambrygen.com/science/scientific-presentation/1/data-double-take-three-examples-of-atypical-pathogenic-alterations-detected-in-exome-sequencing-data 2026-04-02T13:48:18+00:00 https://ambrygen.com/science/scientific-presentation/2/germline-genetic-testing-in-unselected-pancreatic-ductal-adenocarcinoma-pdac-patients 2026-04-02T13:48:18+00:00 https://ambrygen.com/science/scientific-presentation/3/is-this-brain-tumor-genetic-assessment-and-evaluation-for-hereditary-causes-of-primary-brain-tumors 2026-04-02T13:48:19+00:00 https://ambrygen.com/science/scientific-presentation/4/knocking-out-a-titan-assessing-the-effect-of-truncating-ttn-alterations-in-a-large-clinical-cohort 2026-04-02T13:48:19+00:00 https://ambrygen.com/science/scientific-presentation/5/genetic-testing-in-the-epilepsies-testing-options-diagnostic-yield-and-unique-challenges-in-variant-interpretation 2026-04-02T13:48:19+00:00 https://ambrygen.com/science/scientific-presentation/6/breast-cancer-risks-associated-with-mutations-in-cancer-predisposition-genes-identified-by-clinical-genetic-testing-of-50000-breast-cancer-patients 2026-04-02T13:48:19+00:00 https://ambrygen.com/science/scientific-presentation/7/tumor-predisposition-and-genetic-risk-assessment-in-a-neuro-oncology-practice 2026-04-02T13:48:19+00:00 https://ambrygen.com/science/scientific-presentation/8/germline-mutations-in-individuals-with-meningioma-and-breast-cancer 2026-04-02T13:48:19+00:00 https://ambrygen.com/science/scientific-presentation/9/reframing-what-we-already-know-sales-and-marketing-101-for-genetic-counselors 2026-04-02T13:48:19+00:00 https://ambrygen.com/science/scientific-presentation/10/cancer-risks-associated-with-predisposition-gene-mutations-identified-by-hereditary-cancer-panel-testing-of-85000-patients 2026-04-02T13:48:19+00:00 https://ambrygen.com/science/scientific-presentation/11/breast-and-colorectal-cancer-risk-in-monoallelic-mutyh-carriers-ascertained-via-multi-gene-panel-testing 2026-04-02T13:48:19+00:00 https://ambrygen.com/science/scientific-presentation/12/msh6-and-pms2-carriers-identified-by-multi-gene-testing-may-have-a-breast-ovarian-cancer-phenotype 2026-04-02T13:48:19+00:00 https://ambrygen.com/science/scientific-presentation/13/brca2-mutation-carriers-may-present-with-primary-brain-tumors-a-review-of-a-multigene-panel-testing-cohort 2026-04-02T13:48:19+00:00 https://ambrygen.com/science/scientific-presentation/14/prenatal-exome-sequencing-issues-of-clinical-utility-and-beyond 2026-04-02T13:48:19+00:00 https://ambrygen.com/science/scientific-presentation/15/to-disclose-or-not-to-disclose-an-investigation-of-counselor-self-disclosure-in-the-field-of-genetic-counseling 2026-04-02T13:48:19+00:00 https://ambrygen.com/science/scientific-presentation/16/whole-exome-sequencing-in-the-epilepsies-the-developing-diagnostic-exome-signature-of-epilepsy-genes-over-a-five-year-period 2026-04-02T13:48:19+00:00 https://ambrygen.com/science/scientific-presentation/17/ambryshare-a-model-for-sharing-genomic-data-to-understand-all-human-disease 2026-04-02T13:48:19+00:00 https://ambrygen.com/science/scientific-presentation/18/clinical-laboratories-implement-the-acmg-amp-guidelines-to-resolve-differences-in-variant-interpretations-submitted-to-clinvar 2026-04-02T13:48:19+00:00 https://ambrygen.com/science/scientific-presentation/19/msh6-and-pms2-mutation-carriers-ascertained-through-multi-gene-panel-testing-may-present-with-a-hereditary-breast-and-ovarian-cancer-phenotype 2026-04-02T13:48:19+00:00 https://ambrygen.com/science/scientific-presentation/20/a-journey-into-the-unknown-exploring-the-clinical-diagnostic-path-from-targeted-panel-to-whole-exome-sequencing 2026-04-02T13:48:19+00:00 https://ambrygen.com/science/scientific-presentation/21/breast-and-ovarian-cancer-risks-beyond-brca1-2-from-a-cohort-of-15000-women-undergoing-multigene-panel-testing 2026-04-02T13:48:19+00:00 https://ambrygen.com/science/scientific-presentation/22/diagnostic-exome-sequencing-is-successful-in-providing-diagnoses-among-patients-with-intellectual-disability-and-developmental-delay-strong-family-history-correlates-with-an-increased-novel-genetic-e 2026-04-02T13:48:19+00:00 https://ambrygen.com/science/scientific-presentation/23/bevacizumab-impact-on-hearing-loss-due-to-neurofibromatosis-type-2-associated-vestibular-schwannomas-and-associated-biomarkers 2026-04-02T13:48:19+00:00 https://ambrygen.com/science/scientific-presentation/24/evaluation-of-a-multi-gene-panel-test-for-inherited-paragangliomas-and-pheochromocytomas-is-it-time-to-re-assess-guidelines-for-genetic-testing 2026-04-02T13:48:19+00:00 https://ambrygen.com/science/scientific-presentation/25/clinical-diagnostic-exome-sequencing-identified-compound-heterozygous-aspm-gene-alterations-in-a-fetus-with-marked-microcephaly 2026-04-02T13:48:19+00:00 https://ambrygen.com/science/scientific-presentation/26/rising-to-the-level-of-clinical-importance-challenges-to-adjudicating-and-reporting-variants-discovered-with-genomic-analysis 2026-04-02T13:48:19+00:00 https://ambrygen.com/science/scientific-presentation/27/de-novo-mutations-of-kiaa2022-in-females-cause-epileptic-encephalopathy 2026-04-02T13:48:19+00:00 https://ambrygen.com/science/scientific-presentation/28/diagnostic-exome-sequencing-in-a-prenatal-setting 2026-04-02T13:48:19+00:00 https://ambrygen.com/science/scientific-presentation/29/the-importance-of-data-sharing-in-classification-of-variants-in-mismatch-repair-genes 2026-04-02T13:48:19+00:00 https://ambrygen.com/science/scientific-presentation/30/resolving-variant-interpretation-differences-in-clinvar-between-43-clinical-laboratories 2026-04-02T13:48:19+00:00 https://ambrygen.com/science/scientific-presentation/31/phenotype-and-colorectal-cancer-risk-in-apc-i1307k-homozygotes 2026-04-02T13:48:20+00:00 https://ambrygen.com/science/scientific-presentation/32/up-front-vs-post-reporting-parental-co-segregation-analysis-is-one-approach-superior 2026-04-02T13:48:20+00:00 https://ambrygen.com/science/scientific-presentation/33/whats-loss-got-to-do-with-it-working-with-grief-as-a-genetic-counselor 2026-04-02T13:48:20+00:00 https://ambrygen.com/science/scientific-presentation/34/navigating-variant-interpretation-differences-in-cardiovascular-genetics-emerging-data-perspectives-from-clinicians-laboratories 2026-04-02T13:48:20+00:00 https://ambrygen.com/science/scientific-presentation/35/the-expanding-genetic-counseling-landscape-for-cancers-of-childhood-blood-and-brain 2026-04-02T13:48:20+00:00 https://ambrygen.com/science/scientific-presentation/36/inside-pandoras-box-implications-of-acmg-secondary-findings-for-cardiology-oncology-clinical-practice-inside-scoop-from-the-laboratory-a-review-of-lab-based-outcomes-research 2026-04-02T13:48:20+00:00 https://ambrygen.com/science/scientific-presentation/37/de-novo-germline-variants-in-histone-3-family-3a-h3f3a-and-histone-3-family-3b-h3f3b-associated-with-a-severe-neurodegenerative-disorder-and-functional-effect-unique-from-their-somatic-mutat 2026-04-02T13:48:20+00:00 https://ambrygen.com/science/scientific-presentation/38/resolving-variant-interpretation-differences-in-clinvar-between-43-clinical-laboratories 2026-04-02T13:48:20+00:00 https://ambrygen.com/science/scientific-presentation/39/de-novo-mutations-in-protein-kinase-genes-camk2a-and-camk2b-cause-intellectual-disability 2026-04-02T13:48:20+00:00 https://ambrygen.com/science/scientific-presentation/40/prevalence-of-mutations-in-a-large-series-of-clinically-ascertained-ovarian-cancer-cases-tested-on-multi-gene-panels-compared-to-reference-controls 2026-04-02T13:48:20+00:00 https://ambrygen.com/science/scientific-presentation/41/gene-specific-allele-frequency-thresholds-for-benign-evidence-to-empower-variant-interpretation 2026-04-02T13:48:20+00:00 https://ambrygen.com/science/scientific-presentation/42/coverage-matters-high-rate-of-promoter-1b-deletions-in-a-large-apc-testing-cohort 2026-04-02T13:48:20+00:00 https://ambrygen.com/science/scientific-presentation/43/prevalence-of-mutations-in-adenomatous-polyposis-and-colorectal-cancer-associated-genes-in-patients-with-multiple-colon-polyps-stratified-by-age 2026-04-02T13:48:20+00:00 https://ambrygen.com/science/scientific-presentation/44/germline-mutation-prevalence-in-consecutive-unselected-individuals-with-pancreatic-adenocarcinoma 2026-04-02T13:48:20+00:00 https://ambrygen.com/science/scientific-presentation/45/prevalence-of-mutations-in-adenomatous-polyposis-and-colorectal-cancer-associated-genes-in-patients-with-multiple-colon-polyps-stratified-by-age 2026-04-02T13:48:20+00:00 https://ambrygen.com/science/scientific-presentation/46/multiple-findings-in-diagnostic-exome-sequencing-separate-or-intertwined-diagnoses 2026-04-02T13:48:20+00:00 https://ambrygen.com/science/scientific-presentation/47/an-inside-look-at-mosaic-findings-in-cancer-susceptibility-genes-during-one-year-at-a-clinical-diagnostic-laboratory 2026-04-02T13:48:20+00:00 https://ambrygen.com/science/scientific-presentation/48/defining-value-based-practices-for-clinical-laboratories-quality-flexibility-and-collaboration 2026-04-02T13:48:20+00:00 https://ambrygen.com/science/scientific-presentation/49/sanger-confirmation-of-ngs-data 2026-04-02T13:48:20+00:00 https://ambrygen.com/science/scientific-presentation/50/are-gleason-score-and-metastatic-disease-status-important-for-men-with-prostate-cancer-undergoing-multigene-panel-testing 2026-04-02T13:48:20+00:00 https://ambrygen.com/science/scientific-presentation/51/functional-assays-identify-clinically-actionable-variants-in-hereditary-breast-and-ovarian-cancer-predisposition-genes 2026-04-02T13:48:20+00:00 https://ambrygen.com/science/scientific-presentation/52/biallelic-mutations-in-the-ferredoxin-reductase-gene-cause-novel-mitochondriopathy-with-optic-atrophy 2026-04-02T13:48:20+00:00 https://ambrygen.com/science/scientific-presentation/53/phenotypic-expression-of-cdh1-germline-mutations-unselected-for-hereditary-diffuse-gastric-cancer 2026-04-02T13:48:20+00:00 https://ambrygen.com/science/scientific-presentation/54/multi-gene-panels-vs-diagnostic-exome-sequencing-a-comparison-of-genetic-testing-options-for-neurodevelopmental-disorders 2026-04-02T13:48:20+00:00 https://ambrygen.com/science/scientific-presentation/55/polygenic-risk-score-for-breast-cancer-in-high-risk-women 2026-04-02T13:48:20+00:00 https://ambrygen.com/science/scientific-presentation/56/explaining-an-atypical-immunohistochemical-pattern-using-paired-tumor-germline-testing-for-lynch-syndrome 2026-04-02T13:48:20+00:00 https://ambrygen.com/science/scientific-presentation/57/in-a-class-all-by-itself-the-importance-of-reclassifying-genes-and-variants-to-better-guide-patient-care 2026-04-02T13:48:20+00:00 https://ambrygen.com/science/scientific-presentation/58/a-collaborative-view-of-genomic-variant-interpretation-clinical-genetic-counselors-laboratories-and-patients 2026-04-02T13:48:20+00:00 https://ambrygen.com/science/scientific-presentation/59/three-quarters-of-upgraded-negative-reports-due-to-reclassification-are-due-to-lab-initiated-proactive-reanalysis 2026-04-02T13:48:20+00:00 https://ambrygen.com/science/scientific-presentation/60/germline-genetic-associations-with-high-risk-prostate-cancer-and-age-at-diagnosis 2026-04-02T13:48:21+00:00 https://ambrygen.com/science/scientific-presentation/61/genetic-risk-score-predicts-early-age-of-onset-of-prostate-cancer 2026-04-02T13:48:21+00:00 https://ambrygen.com/science/scientific-presentation/63/genetic-testing-updates-for-surgeons-presentation 2026-04-02T13:48:21+00:00 https://ambrygen.com/science/scientific-presentation/64/reclassification-of-splicing-vus-in-neurological-disease-genes-via-rna-seq 2026-04-02T13:48:21+00:00 https://ambrygen.com/science/scientific-presentation/65/high-throughput-rna-splicing-profile-increases-detection-of-clinically-actionable-variants-while-reducing-inconclusive-results-in-patients-with-hereditary-cancer-predisposition 2026-04-02T13:48:21+00:00 https://ambrygen.com/science/scientific-presentation/66/the-new-gc-in-town-demystifying-the-role-of-gene-curation-in-variant-interpretation-clinical-reporting-and-case-reanalysis 2026-04-02T13:48:21+00:00 https://ambrygen.com/science/scientific-presentation/67/clarity-in-chaos-using-somatic-genetic-testing-to-inform-germline-interpretation 2026-04-02T13:48:21+00:00 https://ambrygen.com/science/scientific-presentation/68/the-r659q-and-k618a-mlh1-variants-of-uncertain-significance-and-benign-independently-are-pathogenic-when-inherited-in-cis 2026-04-02T13:48:21+00:00 https://ambrygen.com/science/scientific-presentation/69/predicted-truncating-variants-in-smarca4-may-be-innocent-the-importance-of-multi-institutional-collaboration 2026-04-02T13:48:21+00:00 https://ambrygen.com/science/scientific-presentation/70/when-opportunity-knocks-build-a-door-an-interactive-session-to-build-successful-business-cases-to-solve-everyday-challenges 2026-04-02T13:48:21+00:00 https://ambrygen.com/science/scientific-presentation/71/working-9-5-youve-got-passion-and-a-vision-new-ways-to-provide-genetic-counseling 2026-04-02T13:48:21+00:00 https://ambrygen.com/science/scientific-presentation/72/from-bench-to-clinical-report-application-of-rna-and-functional-maves-to-reduce-vus-and-improve-positive-yield-of-genetic-testing 2026-04-02T13:48:21+00:00 https://ambrygen.com/science/scientific-presentation/74/bringing-genetics-into-your-practice-talk-to-your-office-admin 2026-04-02T13:48:21+00:00 https://ambrygen.com/science/scientific-presentation/75/a-deep-dive-into-apc-introns-paired-dna-rna-testing-identifies-novel-fap-and-afap-alleles-in-the-deep-intronic-regions-of-apc 2026-04-02T13:48:21+00:00 https://ambrygen.com/science/scientific-presentation/76/utility-of-rna-testing-in-individuals-at-increased-risk-for-hereditary-or-familial-pancreatic-cancer 2026-04-02T13:48:21+00:00 https://ambrygen.com/science/scientific-presentation/77/disparities-in-the-uptake-of-cascade-genetic-testing-among-family-members-of-mutation-positive-lynch-and-hboc-syndrome-patients 2026-04-02T13:48:21+00:00 https://ambrygen.com/science/scientific-presentation/78/inherited-cancer-susceptibility-gene-mutations-among-patients-with-appendix-cancer 2026-04-02T13:48:21+00:00 https://ambrygen.com/science/scientific-presentation/79/ctnna1-germline-variants-associate-with-a-disease-spectrum-extending-beyond-hereditary-diffuse-gastric-cancer 2026-04-02T13:48:21+00:00 https://ambrygen.com/science/scientific-presentation/80/variant-reclassification-in-a-large-cardiogenetic-testing-cohort-the-importance-of-disease-specific-variant-classification-criteria 2026-04-02T13:48:21+00:00 https://ambrygen.com/science/scientific-presentation/82/classification-of-sequence-variants-in-cancer-susceptibility-genes-today-and-tomorrow 2026-04-02T13:48:21+00:00 https://ambrygen.com/science/scientific-presentation/83/acmg-clingen-amp-cap-standards-for-classifying-sequence-variants 2026-04-02T13:48:21+00:00 https://ambrygen.com/science/scientific-presentation/84/brca1-frameshift-variants-leading-to-extended-incorrect-protein-termini 2026-04-02T13:48:21+00:00 https://ambrygen.com/science/scientific-presentation/85/multiplexed-assays-of-variant-effect-for-all-possible-missense-alterations-located-in-the-dna-binding-domain-of-brca2 2026-04-02T13:48:21+00:00 https://ambrygen.com/science/scientific-presentation/86/functional-and-clinical-characterization-of-brca2-hypomorphic-missense-variants 2026-04-02T13:48:21+00:00 https://ambrygen.com/science/scientific-presentation/87/democratizing-cancer-risk-stratification-hca-healthcares-scalable-approach-using-a-patient-facing-digital-platform 2026-04-02T13:48:21+00:00 https://ambrygen.com/science/scientific-presentation/88/reassessed-and-revealed-patient-and-genetic-counselor-experience-with-proactive-reanalysis 2026-04-02T13:48:22+00:00 https://ambrygen.com/science/scientific-presentation/89/not-all-actionable-variants-in-brca1-and-brca2-are-created-equal-challenges-of-classifying-and-interpreting-reduced-penetrance-variants 2026-04-02T13:48:22+00:00 https://ambrygen.com/science/scientific-presentation/90/addressing-equity-in-exome-sequencing-proactive-reanalysis-helps-to-reduce-racial-ethnic-and-ancestral-disparities 2026-04-02T13:48:22+00:00 https://ambrygen.com/science/scientific-presentation/91/identification-of-high-risk-hereditary-cancer-syndrome-patients-in-a-primary-care-cohort-using-a-patient-facing-risk-stratification-tool 2026-04-02T13:48:22+00:00 https://ambrygen.com/science/scientific-presentation/92/expanding-the-clinical-reach-of-rna-sequencing-evaluating-testing-outcomes-of-concurrent-germline-dna-and-rna-genetic-testing-in-a-cohort-of-43000-individuals-undergoing-hereditary-cancer-testing 2026-04-02T13:48:22+00:00 https://ambrygen.com/science/scientific-presentation/93/implementation-of-a-digital-cancer-risk-assessment-tool-and-genetic-testing-program-in-gastroenterology-practices-throughout-the-u-s-identifies-inherited-cancer-susceptibility-syndromes-in-15-6-of-pa 2026-04-02T13:48:22+00:00 https://ambrygen.com/science/scientific-presentation/94/breast-cancer-risk-associated-with-missense-variants-in-brca2 2026-04-02T13:48:22+00:00 https://ambrygen.com/science/scientific-presentation/95/germline-genetic-testing-use-and-results-after-a-cancer-diagnosis 2026-04-02T13:48:22+00:00 https://ambrygen.com/science/scientific-presentation/96/mutation-spectrum-and-rates-of-variants-of-uncertain-significance-among-african-american-males-undergoing-prostate-cancer-germline-testing-need-for-equity-in-genetic-testing 2026-04-02T13:48:22+00:00 https://ambrygen.com/science/scientific-presentation/97/implementation-of-routine-genetic-screening-in-a-rural-gastrointestinal-clinic-leads-to-the-identification-of-inherited-gastrointestinal-disorders-and-other-cancer-risks-in-20-of-patients-tested 2026-04-02T13:48:22+00:00 https://ambrygen.com/science/scientific-presentation/98/pathogenic-duplications-in-tumor-suppressor-genes-cause-aberrant-mrna-splicing 2026-04-02T13:48:22+00:00 https://ambrygen.com/science/scientific-presentation/99/the-uniform-application-of-protein-functional-data-has-an-impressive-potential-to-resolve-vus-rates-in-brca2 2026-04-02T13:48:22+00:00 https://ambrygen.com/science/scientific-presentation/100/expanding-access-to-genetic-services-at-community-clinics-using-a-virtual-assistant 2026-04-02T13:48:22+00:00 https://ambrygen.com/science/scientific-presentation/102/development-and-validation-of-the-premmplus-clinical-prediction-model-for-multigene-hereditary-cancer-risk-assessment 2026-04-02T13:48:22+00:00 https://ambrygen.com/science/scientific-presentation/103/de-novo-recurrent-variants-in-u2af2-rna-binding-domains-in-an-intellectual-disability-syndrome 2026-04-02T13:48:22+00:00 https://ambrygen.com/science/scientific-presentation/104/a-randomized-controlled-trial-of-video-education-or-in-person-genetic-counseling-for-men-with-prostate-cancer-progen 2026-04-02T13:48:22+00:00 https://ambrygen.com/science/scientific-presentation/105/paired-like-homeobox-gene-phox2b-non-polyalanine-repeat-expansion-mutations-genotype-phenotype-correlation-in-congenital-central-hypoventilation-syndrome-and-later-onset-cchs 2026-04-02T13:48:22+00:00 https://ambrygen.com/science/scientific-presentation/106/diagnostic-exome-sequencing-is-successful-in-providing-diagnoses-among-patients-with-intellectual-disability-and-developmental-delay-strong-family-history-correlates-with-an-increased-novel-genetic-e 2026-04-02T13:48:22+00:00 https://ambrygen.com/science/scientific-presentation/107/somatic-tp53-mutations-detected-in-germline-testing-the-importance-of-phenotypic-correlation-in-cancer-predisposition-testing 2026-04-02T13:48:22+00:00 https://ambrygen.com/science/scientific-presentation/108/a-recurrent-mutation-in-kcna2-in-complicated-autosomal-dominant-spastic-paraplegia-an-expansion-of-the-channelopathy-spectrum-and-a-novel-disease-mechanism 2026-04-02T13:48:22+00:00 https://ambrygen.com/science/scientific-presentation/109/practice-guidelines-2-0-developing-high-quality-clinically-relevant-practice-guidelines 2026-04-02T13:48:22+00:00 https://ambrygen.com/science/scientific-presentation/110/diagnostic-exome-sequencing-as-the-standard-of-care 2026-04-02T13:48:22+00:00 https://ambrygen.com/science/scientific-presentation/111/the-clinical-and-psychosocial-complexities-of-obtaining-a-diagnosis-for-rare-genetic-disorders-navigating-the-diagnostic-odyssey 2026-04-02T13:48:22+00:00 https://ambrygen.com/science/scientific-presentation/112/bringing-elsi-issues-to-life-the-drama-of-dna 2026-04-02T13:48:22+00:00 https://ambrygen.com/science/scientific-presentation/113/the-panel-results-came-back-now-what-do-i-do-cancer-panel-case-presentations-with-your-peers 2026-04-02T13:48:22+00:00 https://ambrygen.com/science/scientific-presentation/114/application-of-rna-sequencing-evidence-improves-equity-in-variant-interpretation 2026-04-02T13:48:22+00:00 https://ambrygen.com/science/scientific-presentation/115/utility-of-targeted-rna-analysis-in-neurological-disorders 2026-04-02T13:48:22+00:00 https://ambrygen.com/science/scientific-presentation/116/testing-with-intention-leveraging-a-standardized-gene-disease-validity-framework-in-the-face-of-evolving-evidence 2026-04-02T13:48:22+00:00 https://ambrygen.com/science/scientific-presentation/117/acmg-amp-cap-clingen-standards-for-sequence-and-copy-number-variant-classification 2026-04-02T13:48:22+00:00 https://ambrygen.com/science/scientific-presentation/118/reduced-penetrance-brca1-and-brca2-pathogenic-variants-in-clinical-germline-genetic-testing 2026-04-02T13:48:23+00:00 https://ambrygen.com/science/scientific-presentation/119/current-work-of-the-apc-subcommittee-of-the-insight-clingen-hereditary-crc-polyposis-variant-curation-expert-panel-interpretation-of-selected-apc-variants-based-on-the-apc-specific-acmg-amp-variant 2026-04-02T13:48:23+00:00 https://ambrygen.com/science/scientific-presentation/120/yale-criteria-for-genetic-testing-in-cases-of-suspected-hereditary-diffuse-gastric-cancer-hdgc-are-more-sensitive-than-igclc-and-ern-genturis-criteria-in-a-large-american-cohort 2026-04-02T13:48:23+00:00 https://ambrygen.com/science/scientific-presentation/121/saturation-genome-editing-based-functional-evaluation-and-clinical-classification-of-brca2-single-nucleotide-variants 2026-04-02T13:48:23+00:00 https://ambrygen.com/science/scientific-presentation/122/systematic-application-of-clingen-insight-apc-specific-acmg-amp-variant-classification-criteria-alleviates-the-burden-of-variants-of-uncertain-significance-in-clinvar-and-lovd-databases 2026-04-02T13:48:23+00:00 https://ambrygen.com/science/scientific-presentation/123/gastric-and-lobular-breast-cancer-prevalence-in-ctnna1-heterozygotes-identified-via-multigene-panel-testing 2026-04-02T13:48:23+00:00 https://ambrygen.com/science/scientific-presentation/124/variant-classification-and-clinical-actionability 2026-04-02T13:48:23+00:00 https://ambrygen.com/science/scientific-presentation/125/racial-and-ethnic-patterns-of-variants-of-uncertain-significance-vus-among-patients-with-early-onset-colorectal-cancer 2026-04-02T13:48:23+00:00 https://ambrygen.com/science/scientific-presentation/126/long-read-sequencing-elucidates-complex-germline-variants-in-individuals-undergoing-hereditary-gastrointestinal-cancer-testing 2026-04-02T13:48:23+00:00 https://ambrygen.com/science/scientific-presentation/127/pancreatic-cancer-is-more-common-than-melanoma-in-non-white-cdkn2a-positive-individuals 2026-04-02T13:48:23+00:00 https://ambrygen.com/science/scientific-presentation/128/innovations-in-genetic-testing 2026-04-02T13:48:23+00:00 https://ambrygen.com/science/scientific-presentation/129/expanding-the-reach-of-paired-dna-and-rna-sequencing-results-from-450000-consecutive-individuals-from-a-hereditary-cancer-cohort 2026-04-02T13:48:23+00:00 https://ambrygen.com/science/scientific-presentation/130/when-clinical-meets-molecular-why-when-and-how-do-ctnna1-germline-variants-cause-hereditary-diffuse-gastric-cancer-development 2026-04-02T13:48:23+00:00 https://ambrygen.com/science/scientific-presentation/131/gastric-and-lobular-breast-cancer-prevalence-in-ctnna1-heterozygotes-identified-via-multigene-panel-testing 2026-04-02T13:48:23+00:00 https://ambrygen.com/science/scientific-presentation/132/finding-more-answers-with-genetic-testing-maximizing-the-diagnostic-yield-of-exome-sequencing 2026-04-02T13:48:23+00:00 https://ambrygen.com/science/scientific-presentation/133/impact-of-rna-sequencing-on-variant-classification-experience-at-a-high-volume-cancer-genetics-center 2026-04-02T13:48:23+00:00 https://ambrygen.com/science/scientific-presentation/134/maximizing-clinical-utility-of-exomes-greater-than-the-sum-of-its-parts 2026-04-02T13:48:23+00:00 https://ambrygen.com/science/scientific-presentation/135/structural-and-functional-components-of-variant-assessment-in-hereditary-breast-and-ovarian-cancer-susceptibility 2026-04-02T13:48:23+00:00 https://ambrygen.com/science/scientific-presentation/136/functional-validation-and-clinical-classification-of-all-missense-variants-characterized-by-saturation-genome-editing-of-rad51c 2026-04-02T13:48:23+00:00 https://ambrygen.com/science/scientific-presentation/139/analysis-of-missense-variants-in-rps20-and-an-association-with-colorectal-cancer-predisposition 2026-04-02T13:48:23+00:00 https://ambrygen.com/science/scientific-presentation/140/beyond-familial-adenomatous-polyposis-using-genotype-phenotype-correlations-to-discern-germline-versus-somatic-status-for-apc-whole-gene-deletions-among-860000-tests 2026-04-02T13:48:23+00:00 https://ambrygen.com/science/scientific-presentation/141/identification-of-de-novo-variants-from-parent-proband-duos-via-long-read-sequencing 2026-04-02T13:48:23+00:00 https://ambrygen.com/science/scientific-presentation/142/a-multiplex-assay-of-variant-effect-mave-of-msh6-enables-accurate-prospective-lynch-syndrome-clinical-variant-interpretation 2026-04-02T13:48:23+00:00 https://ambrygen.com/science/scientific-presentation/143/the-guardian-expanded-newborn-screening-study-short-and-medium-term-follow-up-with-the-first-15000-participants-enrolled 2026-04-02T13:48:23+00:00 https://ambrygen.com/science/scientific-presentation/145/cancer-specific-risks-associated-with-germline-palb2-pathogenic-variants-from-a-large-clinical-genetic-testing-cohort 2026-04-02T13:48:23+00:00 https://ambrygen.com/science/scientific-presentation/146/laboratory-led-initiatives-to-improve-equity-in-genomic-testing 2026-04-02T13:48:23+00:00 https://ambrygen.com/science/scientific-presentation/147/high-risk-identification 2026-04-02T13:48:24+00:00 https://ambrygen.com/science/scientific-presentation/148/fractional-clues-decoding-nf1-variant-pathogenicity-through-low-vaf 2026-04-02T13:48:24+00:00 https://ambrygen.com/science/scientific-presentation/149/clinical-translation-of-a-mutyh-mave-into-a-diagnostic-laboratory-workflow-enables-largescale-vus-resolution 2026-04-02T13:48:24+00:00 https://ambrygen.com/science/scientific-presentation/150/mave-progress-report-how-ambry-genetics-validates-and-deploys-high-throughput-functional-assays 2026-04-02T13:48:24+00:00 https://ambrygen.com/science/scientific-presentation/151/clinical-utility-of-multiplexed-assays-of-variant-effects-maves-in-a-pediatric-cohort 2026-04-02T13:48:24+00:00 https://ambrygen.com/science/scientific-presentation/152/a-multiplex-assay-of-variant-effect-mave-of-msh6-enables-accurate-prospective-lynch-syndrome-clinical-variant-interpretation 2026-04-02T13:48:24+00:00 https://ambrygen.com/science/scientific-presentation/144/trends-of-variant-reclassification-in-a-large-cardiogenetic-testing-cohort 2026-04-27T11:19:53+00:00